Patents by Inventor Michael Roberge

Michael Roberge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Voltage power switch
    Patent number: 11742858
    Abstract: A voltage power switch includes circuitry configured to output a known voltage. The voltage power switch includes a lock circuit configured to output a known state and a voltage level shifter configured to receive an input, the input being based on the known state output by the lock circuit. The voltage power switch, using an output circuit, is configured to output a known voltage level based on an output of the voltage level shifter, wherein the known voltage is one of a high voltage VHI for a fuse programing period or a first non-zero intermediate voltage VMID1 for a non-fuse programming period.
    Type: Grant
    Filed: August 2, 2022
    Date of Patent: August 29, 2023
    Assignee: Marvell Asia Pte, Ltd.
    Inventors: Eric D. Hunt-Schroeder, Darren Anand, Michael Roberge
  • Voltage power switch
    Patent number: 11418195
    Abstract: A voltage power switch includes circuitry configured to output a known voltage. The voltage power switch includes a lock circuit configured to output a known state and a voltage level shifter configured to receive an input, the input being based on the known state output by the lock circuit. The voltage power switch, using an output circuit, is configured to output a known voltage level based on an output of the voltage level shifter, wherein the known voltage is one of a high voltage VHI for a fuse programing period or a first non-zero intermediate voltage VMID1 for a non-fuse programming period.
    Type: Grant
    Filed: July 15, 2021
    Date of Patent: August 16, 2022
    Assignee: Marvell Asia Pte, Ltd.
    Inventors: Eric D. Hunt-Schroeder, Darren Anand, Michael Roberge
  • Biologically active peptides and compositions, their use
    Publication number: 20050171137
    Abstract: This invention relates to derivatives of hemiasterlin or Geodiamolide G having anti-mitotic activities and useful in treating cancer. These derivatives are represented by general formula I, wherein Y, n, R1, R2, R3, R6, R7, R70, R71, R72, R74, and R75 are as defined in the specification.
    Type: Application
    Filed: January 14, 2005
    Publication date: August 4, 2005
    Inventors: Raymond Andersen, John Coleman, Dilip De Silva, Fangming Kong, Edward Piers, Debra Wallace, Michael Roberge, Teresa Allen
  • Biologically active peptides and compositions, their use
    Patent number: 6870028
    Abstract: This invention relates to derivatives of hemiasterlin or Geodiamolide G having anti-mitotic activities and useful in treating cancer. These derivatives are represented by general formula I, wherein Y, n, R1, R2, R3, R6, R7, R70, R71, R72, R74, and R75 are as defined in the specification.
    Type: Grant
    Filed: June 14, 2000
    Date of Patent: March 22, 2005
    Assignees: University of British Columbia, University of Alberta
    Inventors: Raymond Andersen, John Coleman, Dilip De Silva, Fangming Kong, Edward Piers, Debra Wallace, Michael Roberge, Theresa Allen